Just as trendy as CBD, there’s a new kid on the cannabinoid block – that’s CBG, or cannabigerol. Similar to CBD, CBG is non-psychoactive and has a plethora of natural plant benefits that are available ...

In the realm of cannabinoids, CBD and CBG stand as prominent players, each offering distinct benefits. CBD, or cannabidiol, is celebrated for its relaxing properties and potential to alleviate stress.

CBG stands for Cannabigerol, which is one of the many cannabinoids that can be found in the cannabis plant. CBG has been gaining more popularity as of late, as the cannabinoid is said to have many ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

After CBD hit the wellness scene like a bomb, more and more people became curious about hemp’s other cannabinoids for natural relief. While most are familiar with THC — the intoxicating cannabinoid ...

A lesser-known cannabinoid that is gaining in popularity Cannabigerol (CBG) effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It ...

In 2021, a Hemp Industry Daily survey revealed that an unprecedented 43% of American hemp farmers now set aside at least some of their fields for CBG-rich hemp. Cannabigerol (CBG), a distant cousin of ...

The cannabidiol (CBD) market has exploded in recent years, with estimates from 2021 evaluating the global CBD market at a whopping $5.18 billion (and growing).1 The reality is that CBD has become an ...

Cannabidiol (CBD) and cannabigerol (CBG) are cannabinoids present in the cannabis plant. CBD has shown promise in treating anxiety, while CBG may help people with multiple sclerosis. Both could help ...

Two Connecticut entrepreneurs are hoping to take the cannabigerol (CBG) market by storm through a combination of a high-quality product and being one of the first companies to tap into this nascent ...

LOS ANGELES, April 21, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 ...